Insulet breaks ground on $100M manufacturing plant in Acton, Mass.

Insulet broke ground on a $100 million, 350,000-square-foot manufacturing facility in Acton, Massachusetts, to produce its OmniPod insulin management system. The plant is expected to go online in 2019.

“The $100 million, 350,000-square foot plant is being built on a 26-acre lot Billerica, Mass.-based Insulet acquired for $9.3 million in February”massdevice.com

• 2 sources
• massdevice.comInsulet breaks ground on new manufacturing plant in Mass. - MassDeviceBrad PerrielloAug 30, 2017
• drugdeliverybusiness.comInsulet "bets big" on Massachusetts with new manufacturing facility in Acton - Drug Delivery BusinessSarah FaulknerSep 29, 2017

Summarized from public sources; check the original articles before acting on it.